PNC Financial Services Group’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
PL
OAM
EGA
LWAM
PNC Financial Services Group's GMAB Position: Q2 2026 in Review
PNC Financial Services Group reduced its Genmab (GMAB) stake by 6.5% in Q2 2026, selling an estimated $49K and leaving 26,750 shares worth $735K. The position accounts for ﹤0.01% of the portfolio, ranked #1543.
PNC Financial Services Group first reported a position in GMAB in Q3 2019 and has held it in 28 quarters since. The position peaked at $11.3M in Q3 2021. 122 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.
- PNC Financial Services Group held 26,750 shares of Genmab worth $735K as of Q2 2026.
- PNC Financial Services Group sold 1,845 Genmab shares in Q2 2026, an estimated $49K.
- Genmab made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #1543 holding.
- PNC Financial Services Group first reported a position in Genmab in Q3 2019 and has held it in 28 quarters since.
- PNC Financial Services Group's Genmab position peaked at $11.3M in Q3 2021.
- 122 funds tracked by Wall St. Rank held Genmab as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.